• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中高危型子宫内膜癌的系统性盆腔和主动脉淋巴结切除术:淋巴结绘图和淋巴结状态预测因素的识别。

Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.

机构信息

Department of Gynecology and Obstetrics, Charité, Campus Virchow Clinic, University Hospital, Augustenburger Platz 1, 13353 Berlin, Germany.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):199-203. doi: 10.1016/j.ejogrb.2009.12.021. Epub 2010 Jan 22.

DOI:10.1016/j.ejogrb.2009.12.021
PMID:20096987
Abstract

OBJECTIVE

To systematically assess the metastatic pattern of intermediate- and high-risk endometrial cancer in pelvic and para-aortic lymph-nodes and to evaluate risk factors for lymph-node metastases.

STUDY DESIGN

Between 01/2005 and 01/2009 62 consecutive patients with intermediate- and high-risk endometrial cancer who underwent a systematic surgical staging including pelvic and para-aortic lymphadenectomy were enrolled into this study. Patients' characteristics, histological findings, lymph-node localization and involvement, surgical morbidity and relapse data were analyzed. Univariate analysis was performed to define risk factors for lymph-node metastasis.

RESULTS

Of the 13 patients (21%) with positive lymph-nodes (N1), 8 (61.5%) had both pelvic and para-aortic lymph-nodes affected, 2 (15.4%) only para-aortic and 3 (23%) only pelvic lymph-node metastases. Overall, 54% of the N1-patients had positive lymph-nodes above the inferior mesenteric artery (IMA) to the level of the renal veins. Univariate analysis revealed lymph vascular space invasion (p-value: <0.001), vascular-space-invasion (p-value: <0.001) and incomplete tumor resection (p-value: 0.008) as significant risk factors for N1-status. Overall and progression-free survival was not significantly different between N1- and N0-patients.

CONCLUSIONS

Since the proportion of N1-endometrial cancer patients with positive para-aortic lymph-nodes is, at 76%, considerably high, and more than half of them have affected lymph-nodes above the IMA-level, lymphadenectomy for endometrial cancer should be extended up to the renal veins, when indicated. The therapeutic impact of systematic lymphadenectomy on overall and progression-free survival has still to be evaluated in future prospective randomized studies.

摘要

目的

系统评估中高危子宫内膜癌盆腔和腹主动脉旁淋巴结的转移模式,并评估淋巴结转移的危险因素。

研究设计

2005 年 1 月至 2009 年 1 月,62 例中高危子宫内膜癌患者接受了包括盆腔和腹主动脉旁淋巴结清扫术在内的系统手术分期,这些患者被纳入本研究。分析患者的特征、组织学发现、淋巴结定位和受累情况、手术并发症和复发数据。采用单因素分析定义淋巴结转移的危险因素。

结果

在 13 例(21%)淋巴结阳性(N1)的患者中,8 例(61.5%)盆腔和腹主动脉旁淋巴结均受累,2 例(15.4%)仅腹主动脉旁淋巴结受累,3 例(23%)仅盆腔淋巴结受累。总的来说,N1 患者中 54%的阳性淋巴结位于肠系膜下动脉(IMA)以上至肾静脉水平。单因素分析显示,淋巴管侵犯(p 值:<0.001)、血管侵犯(p 值:<0.001)和肿瘤不完全切除(p 值:0.008)是 N1 状态的显著危险因素。N1 组和 N0 组的总生存率和无进展生存率无显著差异。

结论

由于 N1 期子宫内膜癌患者中存在阳性腹主动脉旁淋巴结的比例(76%)相当高,而且超过一半的患者淋巴结受累位于 IMA 以上水平,因此当指征明确时,子宫内膜癌的淋巴结清扫术应扩展至肾静脉水平。系统淋巴结清扫术对总生存率和无进展生存率的治疗影响仍需在未来的前瞻性随机研究中进行评估。

相似文献

1
Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.中高危型子宫内膜癌的系统性盆腔和主动脉淋巴结切除术:淋巴结绘图和淋巴结状态预测因素的识别。
Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):199-203. doi: 10.1016/j.ejogrb.2009.12.021. Epub 2010 Jan 22.
2
Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.淋巴管间隙浸润和主动脉旁阳性淋巴结组数量可预测子宫内膜癌淋巴结阳性患者的生存率。
Gynecol Oncol. 2005 Mar;96(3):651-7. doi: 10.1016/j.ygyno.2004.11.026.
3
Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.系统性淋巴结清扫术与辅助放疗在淋巴结阳性子宫内膜癌患者中的疗效
Gynecol Oncol. 2006 May;101(2):200-8. doi: 10.1016/j.ygyno.2006.01.032. Epub 2006 Feb 28.
4
Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer.主动脉旁淋巴结切除术在淋巴结阳性子宫内膜癌中的潜在治疗作用。
Gynecol Oncol. 2000 Mar;76(3):348-56. doi: 10.1006/gyno.1999.5688.
5
Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.主动脉旁淋巴结切除术可提高中高危子宫内膜癌患者的生存率。
Acta Obstet Gynecol Scand. 2008;87(12):1361-9. doi: 10.1080/00016340802503054.
6
Can we omit para-aorta lymph node dissection in endometrial cancer?我们能否省略子宫内膜癌的腹主动脉旁淋巴结清扫术?
Jpn J Clin Oncol. 2006 Sep;36(9):578-81. doi: 10.1093/jjco/hyl066. Epub 2006 Jul 26.
7
[The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].[盆腔淋巴结清扫术在前列腺癌和膀胱癌治疗中的作用]
Aktuelle Urol. 2005 Jun;36(3):219-29. doi: 10.1055/s-2004-830279.
8
Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium.盆腔及腹主动脉旁淋巴结切除术用于子宫内膜高危子宫内膜样腺癌的手术分期。
Gynecol Oncol. 1993 Dec;51(3):345-8. doi: 10.1006/gyno.1993.1301.
9
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.根治性膀胱切除术和扩大盆腔淋巴结清扫术:仅接受手术治疗的髂总血管分叉以上淋巴结转移患者的生存率。
J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14.
10
Prognostic significance of gross myometrial invasion with endometrial cancer.子宫内膜癌肌层大体浸润的预后意义
Obstet Gynecol. 1996 Sep;88(3):394-8. doi: 10.1016/0029-7844(96)00161-5.

引用本文的文献

1
Surgery for patients with endometrioid-type endometrial cancer: is lymphadenectomy above the inferior mesenteric artery necessary?子宫内膜样型子宫内膜癌患者的手术治疗:肠系膜下动脉水平以上的淋巴结切除术是否必要?
World J Surg Oncol. 2024 Dec 20;22(1):344. doi: 10.1186/s12957-024-03628-7.
2
Current landscape and future perspective of sentinel node mapping in endometrial cancer.子宫内膜癌前哨淋巴结绘图的现状和未来展望。
J Gynecol Oncol. 2018 Nov;29(6):e94. doi: 10.3802/jgo.2018.29.e94.
3
Survival advantage of lymphadenectomy in endometrial cancer.
子宫内膜癌淋巴结清扫术的生存优势。
J Cancer Res Clin Oncol. 2016 May;142(5):1051-60. doi: 10.1007/s00432-015-2109-9. Epub 2016 Jan 8.
4
Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.对于中高危子宫内膜癌患者,应进行至肾静脉水平的淋巴结切除术。
Pathol Oncol Res. 2015 Jul;21(3):803-10. doi: 10.1007/s12253-014-9893-4. Epub 2015 Jan 7.
5
Surgical and systemic management of endometrial cancer: an international survey.子宫内膜癌的手术及综合治疗:一项国际调查
Arch Gynecol Obstet. 2015 Apr;291(4):897-905. doi: 10.1007/s00404-014-3510-3. Epub 2014 Oct 15.
6
The effect of cell type on surgico-pathologic risk factors in endometrial cancer.细胞类型对子宫内膜癌手术病理危险因素的影响。
J Turk Ger Gynecol Assoc. 2011 Mar 1;12(1):9-14. doi: 10.5152/jtgga.2011.03. eCollection 2011.
7
Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.盆腔及腹主动脉旁淋巴结切除术在子宫内膜癌中的作用:当前证据
J Obstet Gynaecol Res. 2014 Feb;40(2):301-11. doi: 10.1111/jog.12344.
8
Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy.当代化疗在 IIIC 期子宫内膜癌中的疗效:组织学二分法。
Gynecol Oncol. 2014 Mar;132(3):578-84. doi: 10.1016/j.ygyno.2014.01.007. Epub 2014 Jan 14.
9
Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.前瞻性评估子宫内膜癌盆腔、腹主动脉旁和高位腹主动脉旁淋巴结转移的发生率。
Gynecol Oncol. 2014 Jan;132(1):38-43. doi: 10.1016/j.ygyno.2013.10.002. Epub 2013 Oct 9.
10
Contemporary clinical management of endometrial cancer.子宫内膜癌的当代临床管理
Obstet Gynecol Int. 2013;2013:583891. doi: 10.1155/2013/583891. Epub 2013 Jun 24.